Lineage Cell Therapeutics, Inc.

Quick facts

Phase 1 pipeline

• AST-OPC1 · Neurology
  AST-OPC1 is a human oligodendrocyte progenitor cell therapy that promotes myelination and repair in spinal cord injuries.
• GRNOPC1
• OPC1

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Lineage Cell Therapeutics, Inc. portfolio CI brief
• Lineage Cell Therapeutics, Inc. pipeline updates RSS